N-(7-(Dimethylamino)-2-decyl-3H-phenothiazin-3-ylidene)-N-methylmethanaminium Iodide

ID: ALA4743169

Chembl Id: CHEMBL4743169

PubChem CID: 162645961

Max Phase: Preclinical

Molecular Formula: C26H38IN3S

Molecular Weight: 424.68

Molecule Type: Unknown

Names and Identifiers

Canonical SMILES:  CCCCCCCCCCc1cc2nc3ccc(N(C)C)cc3sc-2cc1=[N+](C)C.[I-]

Standard InChI:  InChI=1S/C26H38N3S.HI/c1-6-7-8-9-10-11-12-13-14-20-17-23-26(19-24(20)29(4)5)30-25-18-21(28(2)3)15-16-22(25)27-23;/h15-19H,6-14H2,1-5H3;1H/q+1;/p-1

Standard InChI Key:  NKKSMGBLSBGYPD-UHFFFAOYSA-M

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Unknown

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 424.68

Molecular Weight (Monoisotopic): 424.2781

AlogP: 6.18

#Rotatable Bonds: 10

Polar Surface Area: 19.14

Molecular Species: NEUTRAL

HBA: 3

HBD: 0

#RO5 Violations: 1

HBA (Lipinski): 3

HBD (Lipinski): 0

#RO5 Violations (Lipinski): 1

CX Acidic pKa:

CX Basic pKa: 3.12

CX LogP: 3.78

CX LogD: 3.78

Aromatic Rings: 1

Heavy Atoms: 30

QED Weighted: 0.22

Np Likeness Score: -0.85

References

1. Liu J,Bandyopadhyay I,Zheng L,Khdour OM,Hecht SM.  (2020)  Antiferroptotic Activity of Phenothiazine Analogues: A Novel Therapeutic Strategy for Oxidative Stress Related Disease.,  11  (11): [PMID:33214825] [10.1021/acsmedchemlett.0c00293]

Source

Source(1):

• Scientific Literature